reports
Canfor Pulp reports results for the fourth quarter of 2025
Canfor Pulp reports results for the fourth quarter of 2025 VANCOUVER, British Columbia, March 05, 2026 (GLOBE NEWSWIRE) -- Canfor Pulp Products Inc. (“The Company” or “CPPI”) (TSX: CFX) today reported its fourth quarter of 2025 results: Overview. Q4 2025 operating loss of $85.6 million; net loss of $133.6 million, or $2.05 per share. As a result of the prolonged weakness in global pulp markets and the Company's persistent challenges accessing economically viable fibre, an asset write-down and impairment charge totaling $106.5 million was recognized in Q4 2025, which included a write-of...
Canfor reports results for the fourth quarter of 2025.
Canfor reports results for the fourth quarter of 2025. VANCOUVER, British Columbia, March 05, 2026 (GLOBE NEWSWIRE) -- Canfor Corporation (“the Company” or “Canfor”) (TSX: CFP) today reported its fourth quarter of 2025 results: Overview. For the fourth quarter of 2025, the Company reported an operating loss of $415.9 million and a net loss of $390.5 million, equivalent to $3.35 per share.An asset write-down and impairment charge of approximately $320.4 million has been recorded in Q4 2025 (including a $52.5 million write off of a previously recognized deferred tax asset), of which $213....
Baker Hughes Successfully Prices $6.5 Billion and €3 Billion Offerings...
Baker Hughes Successfully Prices $6.5 Billion and €3 Billion Offerings of Senior Notes HOUSTON and LONDON, March 05, 2026 (GLOBE NEWSWIRE) -- Baker Hughes Company (NASDAQ: BKR) (“Baker Hughes” or the “Company”) today successfully priced a $6.5 billion debt offering consisting of five tranches of senior unsecured notes and a €3 billion debt offering consisting of four tranches of senior unsecured notes (collectively, the “notes”): $500 million 4.050% Senior Notes due 2029$1.25 billion 4.350% Senior Notes due 2031$750 million 4.650% Senior Notes due 2033$2 billion 5.000% Senior Notes due 2...
Calidi Biotherapeutics Announces Proposed Public Offering
Calidi Biotherapeutics Announces Proposed Public Offering SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced that it intends to offer and sell, subject to market and other conditions, units consisting of shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, in an underwritten public offering. Each share of common stock or...
Boeing Co: 1 director
A director at Boeing Co bought 2,230 shares at 224.200USD and the significance rating of the trade was 96/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
International Seaways Inc: 4 directors
A director at International Seaways Inc sold 2,635 shares at 75.404USD and the significance rating of the trade was 46/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Veeco Instruments Inc: 1 director
A director at Veeco Instruments Inc sold 50,000 shares at 31.620USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
EQT Corp: 1 director
A director at EQT Corp sold/sold after exercising options 20,000 shares at 60.690USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
Clover Health Investments Corp: 1 director
A director at Clover Health Investments Corp sold 175,000 shares at 2.170USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
Moody's Ratings rates Humana’s junior subordinated notes at Baa3 (hyb)
New York , March 5, 2026 - Moody's Ratings (Moody's) has assigned a Baa3 (hyb) rating to Humana Inc.'s (Humana; NYSE: HUM; senior unsecured debt rated Baa2) proposed issuance of up to $1.25 billion of junior subordinated notes. The notes will be issued under the company's existing shelf registration...
Figma Inc: 3 directors
Three Directors at Figma Inc sold 185,826 shares at between 28.296USD and 29.805USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
TWC Enterprises Limited Announces 2025 Year End Results And Increase I...
TWC Enterprises Limited Announces 2025 Year End Results And Increase In Eligible Dividend KING CITY, Ontario, March 05, 2026 (GLOBE NEWSWIRE) -- Consolidated Financial Highlights (in thousands of dollars except per share amounts)Three months endedYear ended December 31, 2025December 31, 2024December 31, 2025December 31, 2024Net earnings (loss)$ 16,137($4,580)$ 55,629$40,597Basic and diluted earnings (loss) per share$0.67($0.19)$2.29$1.66 Operating Data Three months endedYear ended December 31,2025December 31,2024December 31,2025December 31,2024Canadian Full Privilege Golf Members ...
Freshworks Unifies Global Sales Organization to Accelerate Growth
Freshworks Unifies Global Sales Organization to Accelerate Growth Promotes Chief of Global Field Operations Ian Tickle to Chief Revenue Officer SAN MATEO, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: FRSH), the leading provider of uncomplicated AI-powered software, today announced leadership changes under its CEO and President Dennis Woodside. With employee experience at the forefront of our strategy and revenue growth plans, the Company has decided to unify its global sales organization under its current Chief of Global Field Operations, Ian Tickle. “By unifying our sales or...
NewLake Capital Partners Reports Fourth Quarter and Full-Year 2025 Fin...
NewLake Capital Partners Reports Fourth Quarter and Full-Year 2025 Financial Results; Declared First Quarter 2026 Common Stock Dividend of $0.43 per Share Fourth Quarter 2025 Revenue totaled $12.3 Million Full Year 2025 Revenue totaled $51.1 Million Fourth Quarter 2025 Net Income Attributable to Common Stockholders totaled $6.0 Million, Funds From Operations totaled $10.0 Million, and Adjusted Funds From Operations totaled $10.6 MillionFull Year 2025 Net Income Attributable to Common Stockholders totaled $26.3 Million, Funds From Operations totaled $42.3 Million, and Adjusted Funds From Op...
Jiangsu Yunyi Electric Co Ltd: 1 director
A director at Jiangsu Yunyi Electric Co Ltd bought 150,000 shares at 14.320CNY and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.